Genetic influence of BCAA metabolism on type 2 diabetes and coronary artery disease, independent of traditional risk factors

Read full text Summarise with VIRAT
Authors: Shota Nakamura, Masaru Koido, Yunye He, Yohei Takeuchi, Hiromi Tsuru, Yoji Sagiya, Akiko Nagai, Takayuki Morisaki, Koichi Matsuda, Yoichiro Kamatani
Cited by: 0
References: 58

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Type 2 diabetes (T2D) and cardiovascular disease are major global health burdens. Branched-chain amino acid (BCAA) metabolism has been implicated as a potential therapeutic target, but it remains unclear whether its associations with disease risk are independent of traditional risk factors such as obesity and dyslipidemia. We leveraged genomic structural equation modeling of large-scale genome-wide association studies (GWAS) from European and East Asian populations, including the largest East Asian GWAS of BCAA levels (n = 42,826). We identified a genetic factor influencing BCAA metabolism independently of body mass index and circulating lipid levels. A cross-population polygenic score derived from this factor was associated with hemoglobin A1c, blood glucose, and the onset of both T2D and coronary artery disease. These findings provide the first genetic insight in humans that BCAA metabolism is involved in T2D and CAD beyond traditional risk factors, highlighting its clinical relevance and therapeutic potential.

Fields of Study & Subjects

Genetic Associations and Epidemiology Diabetes Cardiovascular Risks and Lipoproteins Nutrition Genetics and Disease

Publication details

Journal / source
medRxiv
Publication date
30 March 2026
Language
EN
Document type
Preprint